Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8236345 | SB PHARMCO | Composition and use |
Oct, 2022
(1 year, 5 months ago) |
Avandamet is owned by Sb Pharmco.
Avandamet contains Metformin Hydrochloride; Rosiglitazone Maleate.
Avandamet has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Avandamet are:
Avandamet was authorised for market use on 10 October, 2002.
Avandamet is available in tablet;oral dosage forms.
The generics of Avandamet are possible to be released after 07 October, 2022.
Drugs and Companies using METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE ingredient
Market Authorisation Date: 10 October, 2002
Treatment: NA
Dosage: TABLET;ORAL